According to WIRED, Paterna claims it has worked out the molecular signals needed to turn spermatogonial stem cells into ...
The ability to precisely edit the genomes of bacteria has long been a goal of microbiologists. Such technology would enable ...
This year’s American Academy of Neurology meeting included a presentation that could one day set a new treatment standard for ...
Supports early-stage, high-growth North Dakota businesses by matching private angel investments with direct equity or ...
In the book, “Priority Technologies,” MIT faculty analyze how the U.S. can move ahead in multiple key industrial sectors — semiconductors, biotechnology, critical minerals, drones, quantum computing, ...
BioMedWire Editorial Coverage: Biotechnology is undergoing a quiet but profound transformation, one that is reshaping how investors understand value in a sector ...
Telix Pharmaceuticals Ltd (ASX:TLX) has delivered a sharp reminder of how quickly sentiment can swing in biotech — with a ...
An international team led by researchers at QUT has used artificial intelligence to create tiny "smart" proteins that switch ...
Initial results from a high-stakes trial indicate the biotech may have finally found a niche in lymphoma care for a ...
Pichia pastoris (Komagataella phaffii) stands as a central organism in the field of microbial biotechnology, renowned for its robust capabilities in ...
CRISPR Therapeutics is the second largest holding in Cathie Wood's Ark Innovation ETF. Incoming clinical trial data could send the stock soaring this year. Growing sales of Casgevy plus new candidates ...
Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results